Sponsored by

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 376 to 400 of about 5897

Previous 25

Website Changes

01/14/2023

Feinstein Institutes, Northwell Use Ultrasound to Treat Brain Tumors in Novel Clinical Trial

01/14/2023

New drug combination may effectively treat often fatal childhood brain tumor

01/06/2023

Webinar on Focused Ultrasound for the treatment of brain tumors. Monday 1/9/23 at 7pm Eastern

01/06/2023

Musella Foundation Brain Tumor Copay Program now open for new and renewal applications!

01/06/2023

Lifespan researchers announce major breakthrough in brain cancer vaccine trial.

12/29/2022

Cracking the mystery behind a deadly brain cancer

12/19/2022

Webinar on Focused Ultrasound for the treatment of brain tumors

12/16/2022

Autonomous rhythmic activity in glioma networks drives brain tumour growth

12/16/2022

Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma

12/16/2022

Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment

12/08/2022

Musella Foundation Brain Tumor Treatment Copayment Assistance program is now closed to new and renewal patients

12/06/2022

DcVax Webinar with guest speaker Dr Linda Liau posted on our website!

12/05/2022

CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA

12/05/2022

Our webinar with Dr Linda Liau on DcVax is tonight 12/5/22 at 8:30pm Eastern

12/02/2022

Musella Foundation Brain Tumor Copay Program now open for new and renewal applications!

12/01/2022

Cohen Milstein Files Lawsuit on Behalf of Northwest Biotherapeutics Against Major Market Makers for Market Manipulation

12/01/2022

Convection-enhanced delivery of topotecan active in glioblastoma

11/29/2022

Novocure’s Optune® Approved in Canada for the Treatment of Newly Diagnosed and Recurrent Glioblastoma

11/28/2022

Virtual Trials: Causally-validated treatment effects efficiently learned from an observational cancer registry

11/24/2022

Ulixertinib may change childhood brain tumor treatment

11/22/2022

The accelerated approval pathway is evolving in plain sight, with or without congressional help

11/22/2022

Musella Foundation 2022 Highlights

11/22/2022

. PHASE II TRIAL OF SURVAXM PLUS TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA

11/22/2022

The children`s brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science

11/21/2022

DCVAX webinar: Tuesday Nov 29, 2022 at 7pm Eastern

Our privacy / cookie policy has changed.
Click HERE to read it!